driving preemptive clinical intervention · ©2015 immucor, inc. call: 262.754.1058 email:...

Post on 13-Jun-2020

4 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

kSORT is a non-invasive, accurate and precise genomic blood test for monitoring renal transplant rejection and surveillance.

Driving Preemptive Clinical Intervention

Transfuse | Transplant | Transform a life

IMM_636_kSORT_SellSheet_Redesign_2Pg_Final.indd 1 8/10/15 4:07 PM

©2015 Immucor, Inc.

Call: 262.754.1058Email: SORT@immucor.com

kSORT predicts potentially irreversible damage to the allograft 3-4 months before current diagnostic tools •Creatininelevelsandbiopsiesarebothlateindicatorsofinjury

•Bythetimecreatininelevelsareelevated,morethan50%ofkidneyfunctionmaybelost.Creatininelevelsarenothighlyspecificorsensitiveintheirreliabilitytodetectclinicallyrelevantevents.

•Biopsies,thecurrentgoldstandardforassessinggraftstatus,areinvasive,painful,inconvenientandunsuitedforserialmonitoring.Biopsiesyieldinconclusiveresultsasoftenas30%ofthetime.

•kSORTisasurveillanceandmonitoringassayclinicianscanutilizetomeasurealloimmuneresponseovertime.

kSORT: TheNewParadigminPersonalizedTransplantManagement

Cancer/InfectionsOrgan ToxicityMetabolic Disturbance

Acute Cellular Rejection (ACR)Antibody Mediated Rejection (AMR)

IMM_636_kSORT_SellSheet_Redesign_2Pg_Final.indd 2 8/10/15 4:07 PM

top related